Dilated Cardiomyopathy

Clinical Trial Finder

Many patients with dilated cardiomyopathy are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

A Single Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of MYK-491

Condition:   Dilated Cardiomyopathy
Intervention:   Drug: MYK-491 or placebo
Sponsor:   MyoKardia, Inc.
Recruiting - verified February 2017

Metabolomics Study of Cardiomyopathy

Conditions:   Dilated Cardiomyopathy;   Hypertrophic Cardiomyopathy;   Arrhythmogenic Right Ventricular Cardiomyopathy;   Left Ventricular Non-compaction;   Restrictive Cardiomyopathy
Intervention:  
Sponsor:   Beijing Institute of Heart, Lung and Blood Vessel Diseases
Recruiting - verified February 2017

(MitraClip in Non-Responders to Cardiac Resynchronization Therapy)

Condition:   MITRAL REGURGITATION
Intervention:   Device: MITRACLIP
Sponsors:   Hospital Clinic of Barcelona;   Abbott
Recruiting - verified February 2017

A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy

Condition:   LMNA-Related Dilated Cardiomyopathy
Intervention:   Drug: ARRY-371797, p38 inhibitor, oral
Sponsor:   Array BioPharma
Recruiting - verified February 2017